Clinical Trials on Anal Intraepithelial Neoplasia 1 in India
Total 7 results
-
Tata Memorial HospitalCompletedCervical Intraepithelial NeoplasiaIndia
-
JhpiegoJawaharlal Nehru Medical CollegeCompleted
-
Inovio PharmaceuticalsCompletedCervical Intraepithelial NeoplasiaSouth Africa, United States, Korea, Republic of, Canada, Estonia, India, Georgia, Australia, Puerto Rico
-
National Cancer Institute (NCI)CompletedCervical Cancer | Cervical Intraepithelial Neoplasia | HIV/AIDS | Biomarkers | HPVIndia
-
Sanjay Gandhi Postgraduate Institute of Medical...RecruitingBreast Cancer | Tumor Infiltrating Lymphocytes | Programmed Cell Death Ligand 1India
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerCanada, Korea, Republic of, Taiwan, United States, Italy, United Kingdom, Thailand, Russian Federation, India, Belgium, Australia, Poland, Spain, Japan, Brazil, Czechia, Netherlands